Hyoscine Butylbromide: Clinical Overview
Indications
Hyoscine butylbromide is indicated primarily for abdominal cramping and spasm-like pain, particularly in irritable bowel syndrome (IBS), and is recommended as a first-line antispasmodic agent. 1, 2
The medication is effective for:
- IBS-related abdominal pain and cramping - Both AGA and British Society of Gastroenterology guidelines recommend antispasmodics, including hyoscine butylbromide, for IBS symptom management 1, 2
- Recurrent gastric or intestinal spasm-like pain - Clinical trials demonstrate approximately 55-59% reduction in pain intensity within 3 days 3
- On-demand treatment for functional cramping abdominal pain - Patients achieve clinically meaningful pain relief (≥2 points on 11-point scale) within 45 minutes 4
- Off-label uses include diagnostic procedures, general anesthesia, and cervical preparation for gynecological procedures 5, 6
Recommended Dosage
Oral Administration
- Standard dose: 10-20 mg orally, up to 4 times daily
- On-demand use: 20 mg initially, with up to 4 additional 20 mg doses every 30 minutes as needed (maximum 100 mg/day) 4
- Approved for children aged 6 years and older, though safety data exists for younger ages 5
Intravenous Administration
- Diagnostic procedures: 20 mg IV - This dose provides optimal gastroduodenal distension and smooth muscle relaxation 7
- Lower doses (5-10 mg) result in inadequate relaxation and undesirable duodenal-gastric overlay 7
Veterinary Use (for reference)
- 0.3 mg/kg body weight IV slowly 8
Contraindications and Precautions
Absolute Contraindications
- Undiagnosed angle-closure glaucoma - However, patients with a known history of treated glaucoma are NOT at risk and can receive the medication 9
- Myasthenia gravis
- Megacolon
- Mechanical gastrointestinal obstruction
Important Clinical Caveat
The widespread practice of withholding hyoscine butylbromide based on a history of glaucoma is a misconception. A survey found 81.6% of UK radiologists incorrectly withhold the drug when patients report glaucoma history, but only patients with undiagnosed angle-closure glaucoma are at risk - these patients cannot provide a positive history 9. The recommendation is to abandon routine screening for glaucoma history and instead advise patients to seek urgent care if eye pain or visual loss develops.
Relative Contraindications (Use with Caution)
- Cardiac disease - This appears more clinically relevant than glaucoma concerns, with 1.9% of practitioners reporting cardiac complications versus 0.8% reporting glaucoma attacks 9
- Tachyarrhythmias
- Prostatic hypertrophy with urinary retention
- Pyloric stenosis
Common Adverse Effects
Most Frequent Side Effects
The medication is generally well-tolerated with drug-related adverse events occurring in only 3.5% of patients 3:
- Dry mouth - Most common anticholinergic effect 1
- Dizziness 1
- Blurred vision 1
- Transient tachycardia - Lasts approximately 30 minutes 8
- Decreased bowel sounds - Temporary, resolves within 30 minutes 8
- Transient pupillary dilation 8
Tolerability Profile
- No serious adverse events reported in clinical trials 1, 3
- Abdominal pain, bloating, nausea, and constipation may occur but are uncommon 2
- Significantly lower incidence of uterine cramping compared to misoprostol (0% vs 34.3%) when used for cervical preparation 6
Clinical Advantages
Hyoscine butylbromide demonstrates rapid onset of action with clinically meaningful pain relief within 30-45 minutes and approximately 20% pain reduction within the first 30 minutes. 3, 4 The anticholinergic effects are generally mild and self-limiting, making it suitable for both scheduled and on-demand use in managing recurrent abdominal cramping and spasm-like pain.
The medication's safety profile extends across age groups, with evidence supporting use in children as young as 2 days old, though formal approval is for ages 6 and older 5.